{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:35:40Z","timestamp":1786448140797,"version":"build-2736575974"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DZIF Academy","award":["TI 07.005_008_00"],"award-info":[{"award-number":["TI 07.005_008_00"]}]},{"name":"Miosga Foundation"},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01EO2102 INITIALIZE"],"award-info":[{"award-number":["01EO2102 INITIALIZE"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Viruses"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Recurrent urinary tract infections frequently arise from uropathogenic bacteria invading bladder epithelial cells, where they establish persistent intracellular reservoirs. Phages represent a promising therapeutic alternative to antibiotics owing to their host specificity, ability to circumvent antibiotic resistance, and capacity to disrupt biofilms. In this study, we investigated whether lytic phages can gain access to human bladder epithelial cells and are able to target internalized bacteria using an in vitro bladder infection model. We show that phages can enter the bladder epithelium either via direct cellular uptake or through co-invasion with extracellularly infected bacteria. Notably, the presence of extracellular uropathogenic\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    (UPEC) substantially enhanced intracellular phage uptake, revealing a previously unrecognized bacteria-assisted pathway for intracellular phage delivery that may facilitate access to intracellular bacterial reservoirs. Phage treatment prevented epithelial infection by UPEC and preserved urothelial cell integrity. Moreover, phages reduced intracellular bacterial burden, although complete eradication was not achieved and efficacy was limited to early stages of infection. Together, these findings advance understanding of phage\u2013pathogen\u2013human interactions to optimize phage-based strategies for recurrent urinary tract infections.\n                  <\/jats:p>","DOI":"10.1038\/s44298-026-00222-4","type":"journal-article","created":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T09:21:15Z","timestamp":1786440075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mechanistic insights into phage dynamics to overcome intracellular bacterial reservoirs in urinary tract infections"],"prefix":"10.1038","volume":"4","author":[{"given":"Simone C.","family":"Lieberknecht-Jouy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajana","family":"Pavlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas J.","family":"Fein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathias","family":"M\u00fcsken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Weirauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika Y.","family":"Classen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Tyc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"W\u00fcrstle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Wichelhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J. G. T.","family":"Vehreschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"222_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.888205","volume":"10","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. Disease burden and long-term trends of urinary tract infections: a worldwide report. Front Public Health 10, 888205 (2022).","journal-title":"Front Public Health"},{"key":"222_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s41043-025-00950-y","volume":"44","author":"L Li","year":"2025","unstructured":"Li, L. et al. Global, regional, and national lifetime probabilities of urinary tract infections and interstitial nephritis from 1990 to 2021. J. Health, Popul. Nutr. 44, 231 (2025).","journal-title":"J. Health, Popul. Nutr."},{"key":"222_CR3","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrmicro3432","volume":"13","author":"AL Flores-Mireles","year":"2015","unstructured":"Flores-Mireles, A. L., Walker, J. N., Caparon, M. & Hultgren, S. J. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat. Rev. Microbiol 13, 269\u2013284 (2015).","journal-title":"Nat. Rev. Microbiol"},{"key":"222_CR4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/JU.0000000000000296","volume":"202","author":"J Anger","year":"2019","unstructured":"Anger, J. et al. Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU Guideline. J. Urol. 202, 282\u2013289 (2019).","journal-title":"J. Urol."},{"key":"222_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eururo.2024.03.035","volume":"86","author":"J Kranz","year":"2024","unstructured":"Kranz, J. et al. European Association of Urology Guidelines on Urological Infections: Summary of the 2024 Guidelines. Eur. Urol. 86, 27\u201341 (2024).","journal-title":"Eur. Urol."},{"key":"222_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.chom.2019.01.014","volume":"25","author":"KE Kortright","year":"2019","unstructured":"Kortright, K. E., Chan, B. K., Koff, J. L. & Turner, P. E. Phage Therapy: A Renewed Approach to Combat Antibiotic-Resistant Bacteria. Cell Host Microbe 25, 219\u2013232 (2019).","journal-title":"Cell Host Microbe"},{"key":"222_CR7","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3389\/fmicb.2017.00981","volume":"8","author":"ST Abedon","year":"2017","unstructured":"Abedon, S. T., Garc\u00eda, P., Mullany, P. & Aminov, R. Editorial: Phage Therapy: Past, Present and Future. Front Microbiol 8, 981 (2017).","journal-title":"Front Microbiol"},{"key":"222_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-394805-2.00001-4","volume":"78","author":"BK Chan","year":"2012","unstructured":"Chan, B. K. & Abedon, S. T. Phage therapy pharmacology phage cocktails. Adv. Appl Microbiol 78, 1\u201323 (2012).","journal-title":"Adv. Appl Microbiol"},{"key":"222_CR9","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.mib.2017.09.004","volume":"39","author":"DP Pires","year":"2017","unstructured":"Pires, D. P., Melo, L., Vilas Boas, D., Sillankorva, S. & Azeredo, J. Phage therapy as an alternative or complementary strategy to prevent and control biofilm-related infections. Curr. Opin. Microbiol 39, 48\u201356 (2017).","journal-title":"Curr. Opin. Microbiol"},{"key":"222_CR10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.tim.2008.11.002","volume":"17","author":"RM Donlan","year":"2009","unstructured":"Donlan, R. M. Preventing biofilms of clinically relevant organisms using bacteriophage. Trends Microbiol 17, 66\u201372 (2009).","journal-title":"Trends Microbiol"},{"key":"222_CR11","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrurol.2010.190","volume":"7","author":"B Foxman","year":"2010","unstructured":"Foxman, B. The epidemiology of urinary tract infection. Nat. Rev. Urol. 7, 653\u2013660 (2010).","journal-title":"Nat. Rev. Urol."},{"key":"222_CR12","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.3389\/fmicb.2020.01509","volume":"11","author":"P Loubet","year":"2020","unstructured":"Loubet, P. et al. Alternative therapeutic options to antibiotics for the treatment of urinary tract infections. Front Microbiol 11, 1509 (2020).","journal-title":"Front Microbiol"},{"key":"222_CR13","doi-asserted-by":"publisher","first-page":"16518","DOI":"10.1074\/jbc.RA118.003499","volume":"293","author":"WJ Kim","year":"2018","unstructured":"Kim, W. J., Shea, A. E., Kim, J. H. & Daaka, Y. Uropathogenic Escherichia coli invades bladder epithelial cells by activating kinase networks in host cells. J. Biol. Chem. 293, 16518\u201316527 (2018).","journal-title":"J. Biol. Chem."},{"key":"222_CR14","doi-asserted-by":"crossref","unstructured":"Nguyen, S. et al. Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mBio 8, e01874\u201317 (2017).","DOI":"10.1128\/mBio.01874-17"},{"key":"222_CR15","doi-asserted-by":"crossref","unstructured":"Bichet, M. C. et al. Bacteriophage uptake by mammalian cell layers represents a potential sink that may impact phage therapy. Iscience 24, 102287 (2021).","DOI":"10.1016\/j.isci.2021.102287"},{"key":"222_CR16","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1146\/annurev-virology-111821-111322","volume":"10","author":"L Kan","year":"2023","unstructured":"Kan, L. & Barr, J. J. A Mammalian Cell\u2019s Guide on How to Process a Bacteriophage. Annu Rev. Virol. 10, 183\u2013198 (2023).","journal-title":"Annu Rev. Virol."},{"key":"222_CR17","doi-asserted-by":"publisher","first-page":"20180158","DOI":"10.1098\/rstb.2018.0158","volume":"374","author":"JS King","year":"2019","unstructured":"King, J. S. & Kay, R. R. The origins and evolution of macropinocytosis. Philos. Trans. R. Soc. B 374, 20180158 (2019).","journal-title":"Philos. Trans. R. Soc. B"},{"key":"222_CR18","doi-asserted-by":"publisher","first-page":"R619","DOI":"10.1016\/j.cub.2021.01.036","volume":"31","author":"S Mylvaganam","year":"2021","unstructured":"Mylvaganam, S., Freeman, S. A. & Grinstein, S. The cytoskeleton in phagocytosis and macropinocytosis. Curr. Biol. 31, R619\u2013R632 (2021).","journal-title":"Curr. Biol."},{"key":"222_CR19","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.addr.2020.07.026","volume":"157","author":"Y Ju","year":"2020","unstructured":"Ju, Y., Guo, H., Edman, M. & Hamm-Alvarez, S. F. Application of advances in endocytosis and membrane trafficking to drug delivery. Adv. drug Deliv. Rev. 157, 118\u2013141 (2020).","journal-title":"Adv. drug Deliv. Rev."},{"key":"222_CR20","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.3389\/fimmu.2020.01066","volume":"11","author":"E Uribe-Querol","year":"2020","unstructured":"Uribe-Querol, E. & Rosales, C. Phagocytosis: our current understanding of a universal biological process. Front. Immunol. 11, 1066 (2020).","journal-title":"Front. Immunol."},{"key":"222_CR21","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.3389\/fmicb.2016.01681","volume":"7","author":"M \u017baczek","year":"2016","unstructured":"\u017baczek, M. et al. Antibody production in response to staphylococcal MS-1 phage cocktail in patients undergoing phage therapy. Front. Microbiol. 7, 1681 (2016).","journal-title":"Front. Microbiol."},{"key":"222_CR22","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1002\/adhm.201400508","volume":"4","author":"Y Tian","year":"2015","unstructured":"Tian, Y. et al. Probing the endocytic pathways of the filamentous bacteriophage in live cells using ratiometric pH fluorescent indicator. Adv. Health. Mater. 4, 413\u2013419 (2015).","journal-title":"Adv. Health. Mater."},{"key":"222_CR23","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.3390\/antibiotics10101202","volume":"10","author":"SG Sanmukh","year":"2021","unstructured":"Sanmukh, S. G. et al. Exposure to bacteriophages T4 and M13 increases integrin gene expression and impairs migration of human PC-3 prostate cancer cells. Antibiotics 10, 1202 (2021).","journal-title":"Antibiotics"},{"key":"222_CR24","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.3390\/v7082845","volume":"7","author":"J Majewska","year":"2015","unstructured":"Majewska, J. et al. Oral application of T4 phage induces weak antibody production in the gut and in the blood. Viruses 7, 4783\u20134799 (2015).","journal-title":"Viruses"},{"key":"222_CR25","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1084\/jem.120.5.943","volume":"120","author":"R Aronow","year":"1964","unstructured":"Aronow, R., Danon, D., Shahar, A. & Aronson, M. Electron microscopy of in vitro endocytosis of T2 phage by cells from rabbit peritoneal exudate. J. Exp. Med. 120, 943 (1964).","journal-title":"J. Exp. Med."},{"key":"222_CR26","doi-asserted-by":"publisher","first-page":"e28364","DOI":"10.4161\/bact.28364","volume":"4","author":"Z Ka\u017amierczak","year":"2014","unstructured":"Ka\u017amierczak, Z. et al. Molecular imaging of T4 phage in mammalian tissues and cells. Bacteriophage 4, e28364 (2014).","journal-title":"Bacteriophage"},{"key":"222_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02057-3","volume":"8","author":"TA Lehti","year":"2017","unstructured":"Lehti, T. A., Pajunen, M. I., Skog, M. S. & Finne, J. Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells. Nat. Commun. 8, 1915 (2017).","journal-title":"Nat. Commun."},{"key":"222_CR28","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41385-022-00565-0","volume":"15","author":"NV Jafari","year":"2022","unstructured":"Jafari, N. V. & Rohn, J. L. The urothelium: a multi-faceted barrier against a harsh environment. Mucosal Immunol. 15, 1127\u20131142 (2022).","journal-title":"Mucosal Immunol."},{"key":"222_CR29","doi-asserted-by":"publisher","first-page":"4572","DOI":"10.1128\/IAI.69.7.4572-4579.2001","volume":"69","author":"MA Mulvey","year":"2001","unstructured":"Mulvey, M. A., Schilling, J. D. & Hultgren, S. J. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69, 4572\u20134579 (2001).","journal-title":"Infect. Immun."},{"key":"222_CR30","doi-asserted-by":"publisher","first-page":"e70160","DOI":"10.1111\/apha.70160","volume":"242","author":"S Infante-Tadeo","year":"2026","unstructured":"Infante-Tadeo, S. & Barber, D. L. Lysosome pH Dynamics in Physiology and Disease: Molecular Mechanisms and Therapeutic Insights. Acta Physiol. (Oxf.) 242, e70160 (2026).","journal-title":"Acta Physiol. (Oxf.)"},{"key":"222_CR31","doi-asserted-by":"publisher","first-page":"6124","DOI":"10.1002\/cam4.1820","volume":"7","author":"Y Feng","year":"2018","unstructured":"Feng, Y. et al. Lactate dehydrogenase A: A key player in carcinogenesis and potential target in cancer therapy. Cancer Med 7, 6124\u20136136 (2018).","journal-title":"Cancer Med"},{"key":"222_CR32","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/1097-0134(20010501)43:2<175::AID-PROT1029>3.0.CO;2-#","volume":"43","author":"JA Read","year":"2001","unstructured":"Read, J. A., Winter, V. J., Eszes, C. M., Sessions, R. B. & Brady, R. L. Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. Proteins 43, 175\u2013185 (2001).","journal-title":"Proteins"},{"key":"222_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040329","volume":"4","author":"DA Rosen","year":"2007","unstructured":"Rosen, D. A., Hooton, T. M., Stamm, W. E., Humphrey, P. A. & Hultgren, S. J. Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med 4, e329 (2007).","journal-title":"PLoS Med"},{"key":"222_CR34","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.ijantimicag.2014.02.009","volume":"43","author":"N Abed","year":"2014","unstructured":"Abed, N. & Couvreur, P. Nanocarriers for antibiotics: a promising solution to treat intracellular bacterial infections. Int J. Antimicrob. Agents 43, 485\u2013496 (2014).","journal-title":"Int J. Antimicrob. Agents"},{"key":"222_CR35","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1111\/bph.13664","volume":"174","author":"NF Kamaruzzaman","year":"2017","unstructured":"Kamaruzzaman, N. F., Kendall, S. & Good, L. Targeting the hard to reach: challenges and novel strategies in the treatment of intracellular bacterial infections. Br. J. Pharm. 174, 2225\u20132236 (2017).","journal-title":"Br. J. Pharm."},{"key":"222_CR36","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/jac\/dkg189","volume":"51","author":"S Carryn","year":"2003","unstructured":"Carryn, S., Van Bambeke, F., Mingeot-Leclercq, M. P. & Tulkens, P. M. Activity of beta-lactams (ampicillin, meropenem), gentamicin, azithromycin and moxifloxacin against intracellular Listeria monocytogenes in a 24 h THP-1 human macrophage model. J. Antimicrob. Chemother. 51, 1051\u20131052 (2003).","journal-title":"J. Antimicrob. Chemother."},{"key":"222_CR37","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1128\/AAC.50.3.841-851.2006","volume":"50","author":"M Barcia-Macay","year":"2006","unstructured":"Barcia-Macay, M., Seral, C., Mingeot-Leclercq, M. P., Tulkens, P. M. & Van Bambeke, F. Pharmacodynamic evaluation of the intracellular activities of antibiotics against Staphylococcus aureus in a model of THP-1 macrophages. Antimicrob. Agents Chemother. 50, 841\u2013851 (2006).","journal-title":"Antimicrob. Agents Chemother."},{"key":"222_CR38","doi-asserted-by":"crossref","unstructured":"Van Belleghem, J. D., D\u0105browska, K., Vaneechoutte, M., Barr, J. J. & Bollyky, P. L. Interactions between bacteriophage, bacteria, and the mammalian immune system. Viruses 11, 10 (2018).","DOI":"10.3390\/v11010010"},{"key":"222_CR39","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/1040841X.2021.1902266","volume":"47","author":"A Goswami","year":"2021","unstructured":"Goswami, A., Sharma, P. R. & Agarwal, R. Combatting intracellular pathogens using bacteriophage delivery. Crit. Rev. Microbiol 47, 461\u2013478 (2021).","journal-title":"Crit. Rev. Microbiol"},{"key":"222_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.102287","volume":"24","author":"MC Bichet","year":"2021","unstructured":"Bichet, M. C. et al. Bacteriophage uptake by mammalian cell layers represents a potential sink that may impact phage therapy. iScience 24, 102287 (2021).","journal-title":"iScience"},{"key":"222_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-35859-6","volume":"8","author":"C M\u00f8ller-Olsen","year":"2018","unstructured":"M\u00f8ller-Olsen, C., Ho, S. F. S., Shukla, R. D., Feher, T. & Sagona, A. P. Engineered K1F bacteriophages kill intracellular Escherichia coli K1 in human epithelial cells. Sci. Rep. 8, 17559 (2018).","journal-title":"Sci. Rep."},{"key":"222_CR42","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1016\/S1286-4579(00)90356-3","volume":"2","author":"R Hsia","year":"2000","unstructured":"Hsia, R., Ohayon, H., Gounon, P., Dautry-Varsat, A. & Bavoil, P. M. Phage infection of the obligate intracellular bacterium, Chlamydia psittaci strain guinea pig inclusion conjunctivitis. Microbes Infect. 2, 761\u2013772 (2000).","journal-title":"Microbes Infect."},{"key":"222_CR43","doi-asserted-by":"publisher","first-page":"4653","DOI":"10.1007\/s00253-014-5643-5","volume":"98","author":"S Kaur","year":"2014","unstructured":"Kaur, S., Harjai, K. & Chhibber, S. Bacteriophage-aided intracellular killing of engulfed methicillin-resistant Staphylococcus aureus (MRSA) by murine macrophages. Appl Microbiol Biotechnol. 98, 4653\u20134661 (2014).","journal-title":"Appl Microbiol Biotechnol."},{"key":"222_CR44","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1086\/343812","volume":"186","author":"L Broxmeyer","year":"2002","unstructured":"Broxmeyer, L. et al. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobacteriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J. Infect. Dis. 186, 1155\u20131160 (2002).","journal-title":"J. Infect. Dis."},{"key":"222_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abq2005","volume":"8","author":"L Meng","year":"2022","unstructured":"Meng, L. et al. Nanocapping-enabled charge reversal generates cell-enterable endosomal-escapable bacteriophages for intracellular pathogen inhibition. Sci. Adv. 8, eabq2005 (2022).","journal-title":"Sci. Adv."},{"key":"222_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2021.113864","volume":"176","author":"W Yan","year":"2021","unstructured":"Yan, W. et al. Formulation strategies for bacteriophages to target intracellular bacterial pathogens. Adv. Drug Deliv. Rev. 176, 113864 (2021).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"222_CR47","first-page":"137","volume":"1","author":"NS Olsen","year":"2020","unstructured":"Olsen, N. S., Hendriksen, N. B., Hansen, L. H. & Kot, W. A new high-throughput screening method for phages: enabling crude isolation and fast identification of diverse phages with therapeutic potential. PHAGE 1, 137\u2013148 (2020).","journal-title":"PHAGE"},{"key":"222_CR48","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.00646-23","volume":"8","author":"M Zhao","year":"2023","unstructured":"Zhao, M. et al. Engineered phage with cell-penetrating peptides for intracellular bacterial infections. mSystems 8, e0064623 (2023).","journal-title":"mSystems"},{"key":"222_CR49","doi-asserted-by":"crossref","unstructured":"Zulk, J. J. et al. Human bladder organoids model urinary tract infection and bacteriophage therapy. bioRxiv (2025).","DOI":"10.1101\/2025.07.30.667685"},{"key":"222_CR50","doi-asserted-by":"crossref","unstructured":"Zhang, L. et al. Intracellular staphylococcus aureus control by virulent bacteriophages within MAC-T Bovine mammary epithelial cells. Antimicrob. Agents Chemother. 61, e01990\u201316 (2017).","DOI":"10.1128\/AAC.01990-16"},{"key":"222_CR51","unstructured":"Joshi, B. et al. Bacteriophage-mediated reduction of uropathogenic E. coli from the urogenital epithelium. bioRxiv (2025)."},{"key":"222_CR52","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1021\/acssynbio.3c00135","volume":"12","author":"J Williams","year":"2023","unstructured":"Williams, J., Kerven, J., Chen, Y. & Sagona, A. P. Genetic Engineering of Bacteriophage K1F with Human Epidermal Growth Factor to Enhance Killing of Intracellular E. coli K1. ACS Synth. Biol. 12, 2094\u20132106 (2023).","journal-title":"ACS Synth. Biol."},{"key":"222_CR53","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.tim.2004.07.005","volume":"12","author":"GG Anderson","year":"2004","unstructured":"Anderson, G. G., Dodson, K. W., Hooton, T. M. & Hultgren, S. J. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis. Trends Microbiol 12, 424\u2013430 (2004).","journal-title":"Trends Microbiol"},{"key":"222_CR54","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1073\/pnas.0308125100","volume":"101","author":"SS Justice","year":"2004","unstructured":"Justice, S. S. et al. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA 101, 1333\u20131338 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"222_CR55","doi-asserted-by":"publisher","first-page":"18944","DOI":"10.1074\/jbc.M400769200","volume":"279","author":"MJ Duncan","year":"2004","unstructured":"Duncan, M. J., Li, G., Shin, J. S., Carson, J. L. & Abraham, S. N. Bacterial penetration of bladder epithelium through lipid rafts. J. Biol. Chem. 279, 18944\u201318951 (2004).","journal-title":"J. Biol. Chem."},{"key":"222_CR56","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1111\/j.1462-5822.2008.01229.x","volume":"10","author":"DS Eto","year":"2008","unstructured":"Eto, D. S., Gordon, H. B., Dhakal, B. K., Jones, T. A. & Mulvey, M. A. Clathrin, AP-2, and the NPXY-binding subset of alternate endocytic adaptors facilitate FimH-mediated bacterial invasion of host cells. Cell Microbiol 10, 2553\u20132567 (2008).","journal-title":"Cell Microbiol"},{"key":"222_CR57","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/j.1472-765X.2007.02190.x","volume":"45","author":"N Cerca","year":"2007","unstructured":"Cerca, N., Oliveira, R. & Azeredo, J. Susceptibility of Staphylococcus epidermidis planktonic cells and biofilms to the lytic action of staphylococcus bacteriophage K. Lett. Appl Microbiol 45, 313\u2013317 (2007).","journal-title":"Lett. Appl Microbiol"},{"key":"222_CR58","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.femsle.2004.06.058","volume":"241","author":"S Sillankorva","year":"2004","unstructured":"Sillankorva, S., Oliveira, R., Vieira, M. J., Sutherland, I. & Azeredo, J. Pseudomonas fluorescens infection by bacteriophage PhiS1: the influence of temperature, host growth phase and media. FEMS Microbiol Lett. 241, 13\u201320 (2004).","journal-title":"FEMS Microbiol Lett."},{"key":"222_CR59","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1099\/00221287-143-1-179","volume":"143","author":"H Hadas","year":"1997","unstructured":"Hadas, H., Einav, M., Fishov, I. & Zaritsky, A. Bacteriophage T4 Development Depends on the Physiology of its Host Escherichia Coli. Microbiology 143, 179\u2013185 (1997).","journal-title":"Microbiology"},{"key":"222_CR60","doi-asserted-by":"publisher","first-page":"00792","DOI":"10.1128\/JB.00792-17","volume":"200","author":"T Reyes-Robles","year":"2018","unstructured":"Reyes-Robles, T. et al. Vibrio cholerae outer membrane vesicles inhibit bacteriophage infection. J. Bacteriol. 200, 00792\u201300717 (2018).","journal-title":"J. Bacteriol."},{"key":"222_CR61","doi-asserted-by":"crossref","unstructured":"Zhou, J. et al. Bacterial outer membrane vesicles: from physics to clinical. MedComm - Biomater. Appl. 4, e70013 (2025).","DOI":"10.1002\/mba2.70013"},{"key":"222_CR62","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.3390\/microorganisms12091836","volume":"12","author":"G Xuan","year":"2024","unstructured":"Xuan, G., Lu, D., Lin, H., Wang, Y. & Wang, J. Outer Membrane Vesicle Production by Escherichia coli Enhances Its Defense against Phage Infection. Microorganisms 12, 1836 (2024).","journal-title":"Microorganisms"},{"key":"222_CR63","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/emboj.2011.286","volume":"30","author":"J Huotari","year":"2011","unstructured":"Huotari, J. & Helenius, A. Endosome maturation. Embo j. 30, 3481\u20133500 (2011).","journal-title":"Embo j."},{"key":"222_CR64","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12223-011-0039-8","volume":"56","author":"E Jo\u0144czyk","year":"2011","unstructured":"Jo\u0144czyk, E., K\u0142ak, M., Mi\u0119dzybrodzki, R. & G\u00f3rski, A. The influence of external factors on bacteriophages-review. Folia Microbiol (Praha) 56, 191\u2013200 (2011).","journal-title":"Folia Microbiol (Praha)"},{"key":"222_CR65","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.cis.2017.05.014","volume":"249","author":"DJ Malik","year":"2017","unstructured":"Malik, D. J. et al. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Adv. Colloid Interface Sci. 249, 100\u2013133 (2017).","journal-title":"Adv. Colloid Interface Sci."},{"key":"222_CR66","doi-asserted-by":"publisher","first-page":"e1011388","DOI":"10.1371\/journal.ppat.1011388","volume":"19","author":"M Naskar","year":"2023","unstructured":"Naskar, M. et al. \u03b1-Hemolysin promotes uropathogenic E. coli persistence in bladder epithelial cells via abrogating bacteria-harboring lysosome acidification. PLoS Pathog. 19, e1011388 (2023).","journal-title":"PLoS Pathog."},{"key":"222_CR67","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.virusres.2017.07.015","volume":"240","author":"N Val\u00e9rio","year":"2017","unstructured":"Val\u00e9rio, N. et al. Effects of single and combined use of bacteriophages and antibiotics to inactivate Escherichia coli. Virus Res 240, 8\u201317 (2017).","journal-title":"Virus Res"},{"key":"222_CR68","unstructured":"Classen, A. Y. Analysis of the lytic capacity and host-range of Escherichia coli bacteriophages using isolates collected from clinical specimens Poster presentation (32nd ECCMID, Lisbon, Portugal, 2022)."},{"key":"222_CR69","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1155\/2006\/329465","volume":"17","author":"AM Kropinski","year":"2006","unstructured":"Kropinski, A. M. Phage Therapy - Everything Old is New Again. Can. J. Infect. Dis. Med Microbiol 17, 297\u2013306 (2006).","journal-title":"Can. J. Infect. Dis. Med Microbiol"},{"key":"222_CR70","doi-asserted-by":"crossref","unstructured":"Adams, M. H. Bacteriophages, (Citeseer, 1959).","DOI":"10.5962\/bhl.title.6966"},{"key":"222_CR71","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.3390\/v14071490","volume":"14","author":"T Glonti","year":"2022","unstructured":"Glonti, T. & Pirnay, J.-P. In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success. Viruses 14, 1490 (2022).","journal-title":"Viruses"},{"key":"222_CR72","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1128\/JCM.41.2.680-688.2003","volume":"41","author":"DJ Park","year":"2003","unstructured":"Park, D. J., Drobniewski, F. A., Meyer, A. & Wilson, S. M. Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum. J. Clin. Microbiol 41, 680\u2013688 (2003).","journal-title":"J. Clin. Microbiol"},{"key":"222_CR73","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/S0923-2508(98)80003-X","volume":"149","author":"R McNerney","year":"1998","unstructured":"McNerney, R. et al. Inactivation of mycobacteriophage D29 using ferrous ammonium sulphate as a tool for the detection of viable Mycobacterium smegmatis and M. tuberculosis. Res. Microbiol. 149, 487\u2013495 (1998).","journal-title":"Res. Microbiol."},{"key":"222_CR74","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/978-1-62703-290-2_7","volume":"979","author":"FK Chan","year":"2013","unstructured":"Chan, F. K., Moriwaki, K. & De Rosa, M. J. Detection of necrosis by release of lactate dehydrogenase activity. Methods Mol. Biol. 979, 65\u201370 (2013).","journal-title":"Methods Mol. Biol."},{"key":"222_CR75","first-page":"2025","volume":"ume 15","author":"F Rieper","year":"2025","unstructured":"Rieper, F. et al. Systematic bacteriophage selection for the lysis of multiple Pseudomonas aeruginosa strains. Front. Cell. Infect. Microbiol. ume 15, 2025 (2025).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"222_CR76","doi-asserted-by":"crossref","unstructured":"Malik, M. N. H. et al. Congenital deficiency reveals critical role of ISG15 in skin homeostasis. J. Clin. Invest. 132, e141573 (2022).","DOI":"10.1172\/JCI141573"},{"key":"222_CR77","unstructured":"R Core Team. The R Project for Statistical Computing. https:\/\/www.r\u2013project.org\/ (2025)."},{"key":"222_CR78","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/nmeth.1896","volume":"9","author":"C Allan","year":"2012","unstructured":"Allan, C. et al. OMERO: flexible, model-driven data management for experimental biology. Nat. Methods 9, 245\u2013253 (2012).","journal-title":"Nat. Methods"}],"container-title":["npj Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00222-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00222-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00222-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:04:56Z","timestamp":1786446296000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44298-026-00222-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,11]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["222"],"URL":"https:\/\/doi.org\/10.1038\/s44298-026-00222-4","relation":{},"ISSN":["2948-1767"],"issn-type":[{"value":"2948-1767","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,11]]},"assertion":[{"value":"20 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"38"}}